EquityZen Growth Technology Fund LLC - Series 355
Raised
$135K
Investors
10
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 355 is a Delaware series LLC filed by EquityZen Advisors that raised $135K from 10 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This is one of nearly 1,900 pre-IPO secondary market SPVs operated by the EquityZen platform, which structures individual series for specific private company equity transactions.
This filing follows the standard EquityZen platform structure for pre-IPO secondary market access: a small pooled investment vehicle using the 506(b) private placement exemption with a relatively accessible $10K minimum. The investor count and total raise suggest retail-scale participation in fractional positions of late-stage private company equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
